Merck & Co., Inc, Merck Research Laboratories (MRL), Rahway, NJ, USA.
Pediatric Department, Princess Grace Hospital, Monaco, Monaco.
Eur J Pediatr. 2024 Dec;183(12):5233-5243. doi: 10.1007/s00431-024-05763-5. Epub 2024 Oct 5.
To estimate the economic burden of varicella among children in France from family and societal perspectives. We conducted an online cross-sectional survey of caregivers of 185 French children (≤ 17 years) diagnosed with varicella in the previous six weeks. Data collected included varicella-related healthcare resource use, out-of-pocket costs, missed school days, and workdays missed by either parents or other caregivers. Mean and median direct and indirect costs (2022 Euros) were calculated using survey data and published literature. The annual societal burden of pediatric varicella in France was estimated. Of the 185 children, 95.1% had ≥ 1 outpatient visit, 10.3% had ≥ 1 emergency room visit, and 2.2% were hospitalized. The median [interquartile range, IQR] number of outpatient visits/child was 1.0 [1.0 - 2.0]. The median length of hospital stay among those hospitalized (n = 4) was 5.0 [3.5 - 6.5] days. Caregivers of 185 children missed a median of 2.0 [0 - 5.0] workdays; 113 families (61.1%) had ≥ 1 parent miss work. A median of 5.0 [3.0 - 7.0] school days were missed by 170 children who attended preschool or school. The median direct out-of-pocket cost to the family was €30.0 [€17.0 - €60.0]. The median [IQR] societal costs per varicella case were €455.2 [€70.5 - €1013.5]; the median [IQR] direct and indirect costs per child were €60.8 [€39.0 - €102.7] and €364.7 [€0.0 - €911.7] respectively. The annual societal burden of varicella among children in France was estimated to be €450,427,578 (95% CI: €357,144,618 - €543,710,538), with indirect costs accounting for 85%.
A substantial economic burden is associated with pediatric varicella in France, primarily due to the productivity loss among caregivers.
• Although varicella is considered a mild disease, it poses a significant burden on caregivers and society. Our study aimed to estimate the economic burden of varicella among children in France from family and societal perspectives to support policymakers in understanding the value of UVV in France.
• We conducted an online survey of caregivers of 185 French children (≤17 years) diagnosed with varicella and collected data on varicella-related healthcare resource use, missed school days and workdays. Our study estimated annual societal burden of pediatric varicella in France. Out of 185 children with varicella, most (95.1%) had at least one outpatient visit, 10.3% had at least one emergency room visit, and 2.2% were hospitalized. 61.1% of parents with sick child, missed work and median productivity loss was 2.0 workdays. Additionally, 170 children who attended school or preschool missed a median of 5.0 school days. • The societal burden of pediatric varicella in France was estimated to be €450,427,578 (95% CI, €357,144,618 - €543,710,538), with indirect costs accounting for 85%. Pediatric varicella is associated with a substantial economic burden in France, primarily due to high productivity losses among parents and caregivers.
从家庭和社会角度估计法国儿童水痘的经济负担。
我们对 185 名在过去六周内被诊断患有水痘的 185 名法国儿童(≤17 岁)的照顾者进行了在线横断面调查。收集的数据包括与水痘相关的医疗资源使用、自付费用、缺课天数和父母或其他照顾者缺勤的工作日。使用调查数据和已发表的文献计算直接和间接成本(2022 欧元)的均值和中位数。估计法国儿科水痘的年度社会负担。
185 名儿童中,95.1%有≥1 次门诊就诊,10.3%有≥1 次急诊就诊,2.2%住院。中位数[四分位距,IQR]每名儿童的门诊就诊次数为 1.0[1.0-2.0]。住院(n=4)儿童的中位住院时间为 5.0[3.5-6.5]天。185 名儿童的照顾者平均缺勤 2.0[0-5.0]个工作日;113 个家庭(61.1%)有≥1 名父母缺勤。170 名上幼儿园或上学的儿童平均缺勤 5.0[3.0-7.0]天。家庭自付费用中位数为 30.0[17.0-60.0]欧元。每例水痘病例的社会成本中位数为 455.2[70.5-1013.5]欧元;每名儿童的直接和间接成本中位数分别为 60.8[39.0-102.7]欧元和 364.7[0.0-911.7]欧元。法国儿童水痘的年度社会负担估计为 450427578 欧元(95%CI:357144618-543710538),间接成本占 85%。
法国儿科水痘给儿童照顾者及其家庭带来了巨大的经济负担。
虽然水痘被认为是一种轻度疾病,但它给照顾者和社会带来了重大负担。我们的研究旨在从家庭和社会角度估计法国儿童水痘的经济负担,以支持决策者了解法国水痘疫苗接种的价值。
我们对 185 名法国儿童(≤17 岁)的照顾者进行了在线调查,并收集了与水痘相关的医疗资源使用、缺课天数和工作日缺勤的数据。我们的研究估计了法国儿科水痘的年度社会负担。在 185 名患有水痘的儿童中,大多数(95.1%)至少有 1 次门诊就诊,10.3%至少有 1 次急诊就诊,2.2%住院。61.1%的患病儿童父母缺勤,平均生产力损失为 2 个工作日。此外,170 名上幼儿园或上学的儿童平均缺勤 5.0 天。法国儿科水痘的社会负担估计为 450427578 欧元(95%CI:357144618-543710538),间接成本占 85%。法国儿童水痘主要与父母和照顾者的高生产力损失有关,给社会带来了巨大的经济负担。